Moderna
MRNA
#1187
Rank
ยฃ12.58 B
Marketcap
ยฃ32.70
Share price
7.48%
Change (1 day)
-47.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -ยฃ3.47 Billion

According to Moderna 's latest financial reports the company's current earnings are ยฃ4.98 Billion. In 2023 the company made an earning of -ยฃ3.11 Billion a decrease over its 2022 earnings that were of ยฃ7.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ3.47 Billion11.45%
2023 -ยฃ3.11 Billion-140.65%
2022 ยฃ7.64 B-27.81%
2021 ยฃ10.58 B-1911.15%
2020 -ยฃ0.59 Billion44.7%
2019 -ยฃ0.41 Billion28.63%
2018 -ยฃ0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ27.85 Million-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ13.11 B-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ33.23 Million-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.15 Billion-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.12 B-395.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-ยฃ0.42 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.63 B-527.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ93.6 Million-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA